Personalized Cancer Stem Cell High-Throughput Drug Screening for Glioblastoma

Clinical trial NCT05380349 · RECRUITING

Trial details

NCT number: NCT05380349
Sponsor: Swedish Medical Center
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Newly Diagnosed Glioblastoma

Start date: 2024-04-19
Primary completion: 2026-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.